News
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...
Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...
Novo Nordisk A/S is hunting for more early-stage deals to pad its pipeline of next-generation obesity drugs, as the drugmaker ...
Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.
Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...
Omnicom's $13.5 billion acquisition of rival Interpublic can move forward on the condition the new company does not enter ...
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
Novo Nordisk A/S’s next-generation obesity shot CagriSema helped patients lose weight in large studies despite only about ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...
Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results